ASH 2010 Conference Coverage

Two-drug combination boosts survival in patients with metastatic prostate cancer

A combination therapy increased survival rates for individuals with newly diagnosed metastatic, hormone-sensitive prostate cancer.

Tell me about your prostate cancer symptoms ... Will most men talk or walk?

Approximately 97% of men with advanced prostate cancer report being comfortable discussing their symptoms with their health care team. But the number of men who actually do so is significantly lower.

Effects of glioblastoma treatments on healthy brain tissue continues after treatment is completed

The first study to examine the effects of combined radiation and chemotherapy on the healthy brain tissue of glioblastoma patients has revealed specific structural brain changes.

Aspirin reverses obesity cancer risk

A regular regimen of aspirin can reduce additional cancer risk for obese individuals, according to study data.

Patient-centered toolkit (PCTK) improves communication between patients, caregivers, and health care team

A novel web-based, patient-centered toolkit (PCTK) helped patients develop their plan of care.

Prophylactic surgery rates among men with breast cancer nearly double

The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011.

Fungal infection drug for lung transplant recipients may increase cancer, death risk

Prescription drug that is commonly used to treat fungal infections in lung transplant recipients may significantly increase the risk for skin cancer.

Long-term denosumab therapy safe for patients with breast, prostate cancer

No new safety signals were identified for long-term denosumab therapy in patients with metastatic breast or prostate cancer and bone metastases.

Children receiving intermediate, high dose MTX experience poor CINV control

Children with cancer receiving methotrexate had a poor complete chemotherapy-induced nausea and vomiting (CINV) rate.

Variation in Medicare reimbursement for radiation therapy not attributed to patient or cancer characteristics

Differences in radiation therapy costs for Medicare patients often have little to do with patient specifics, researchers found.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs